Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

Abstract Background Programmed death-1 (PD-1) inhibitors are among the immunotherapies that have revolutionized our approach to treating several cancers. These novel agents act by blocking PD-1 receptor/PD-1 ligand interactions that would otherwise allow tumor cells to evade host immune destruction...

Full description

Bibliographic Details
Main Authors: Hoda Z. Pourhassan, David Tryon, Brett Schaeffer, Hamid Mirshahidi, John Wong
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Experimental Hematology & Oncology
Subjects:
PD-1
Nivolumab
Melanoma
Immunotherapy
Immune mediated adverse events
Myopathy
Online Access:http://link.springer.com/article/10.1186/s40164-019-0140-2

Internet

http://link.springer.com/article/10.1186/s40164-019-0140-2

Similar Items